Researchers at the Saint Louis University School of Medicine are investigating a new medicine for allergic asthma, and 850 patients with are needed to participate at 150 sites across the country.
Patients enrolled in the study will have a 50 percent chance of being assigned to one of two treatment groups. The first group will receive standard treatment with high-dose inhaled corticosteroids and a long-acting beta-agonist with the addition of the investigational drug for 48 weeks. The second group will receive standard treatment with the addition of a placebo for 48 weeks.
To qualify for the study, men and women between the ages of 12 and 75 must have moderate to severe persistent allergic asthma that is inadequately controlled with standard treatments. To enroll in the study, call 314-977-4440.
(If you decide to participate in the study, please email us and let us know how it goes!)